Frontiers in Pharmacology (Oct 2015)

Commentary: Sphingosine-1-phosphate inhibitors are potential therapeutic targets for pulmonary arterial hypertension

  • Naga P Bhavanam,
  • Athena eFailla,
  • Young eCho,
  • Richard F. Lockey,
  • Narasaiah eKolliputi

DOI
https://doi.org/10.3389/fphar.2015.00229
Journal volume & issue
Vol. 6

Abstract

Read online

No abstracts available.

Keywords